Ascelia Pharma AB (publ) (ACE) — Long-term Investment Intensity
Ascelia Pharma AB (publ) (ACE) has a Long-term Investment Intensity of 0.0% as of December 2018. Long-term investments of Skr1.00K represent 0.0% of total assets of Skr105.46 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore ACE operating cash flow to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Ascelia Pharma AB (publ) Long-term Investment Intensity (2017–2017)
This chart shows how Ascelia Pharma AB (publ)'s Long-term Investment Intensity has evolved across 1 annual periods from 2017 to 2017. As of December 2018, the intensity stands at 0.0%, reflecting long-term investments of Skr1.00K against total assets of Skr105.46 Million SEK. Explore ACE cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Ascelia Pharma AB (publ) (2017–2017)
The table below presents the year-by-year Long-term Investment Intensity for Ascelia Pharma AB (publ) from 2017 to 2017, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Ascelia Pharma AB (publ) market capitalisation.
| Year | LT Investment Intensity | LT Investments (SEK) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 0.0% | Skr1.00K | Skr116.15 Million | — |